There’s no way that we have insufficient interest from Europe. As has been mentioned many times, the market is huge and I believe it will only be restricted by our manufacturing capacity.
Discussions for the US market have been going on for some time and that interview was probably the most bullish I’ve heard DT. He’s previously spoken of possibly licensing the test or contracting out the manufacturing like we currently doing with Operon.
I really like how confident he was with the saliva test. That will be what gets the market (both consumer and stock markets) attention. An accurate Saliva test will be worth billions IMO. Not to downplay it either but the multiplex Flu/Covid test is what will be making money for years after as Covid subsides.
That is the best and most confident that I’ve heard our CEO. This company will become a Goliath.
ADO Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
(20min delay)